Pathohistological and immunohistochemical features of chronic viral hepatitis b progression

Pathohistological and immunohistochemical features of chronic viral hepatitis b progression

Aim. The paper contains the results of a comprehensive study of pathohistological and immunohistochemical liver biopsies of 50 patients with chronic hepatitis B in relation to clinical and biochemical parameters to improve the most significant microscopic criteria of chronic hepatitis B progression...

Full description

Bibliographic Details
Main Author:	M. A. Shishkin
Format:	Article
Language:	English
Published:	Zaporozhye State Medical University 2015-04-01
Series:	Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki
Subjects:	Hepatitis B Chronic Liver Stellate Cells Fibroblasts
Online Access:	http://pharmed.zsmu.edu.ua/article/view/41700/38159

Similar Items

Pathohistological and immunohistochemical features of chronic hepatitis C progression
by: M. A. Shishkin
Published: (2015-02-01)

Morphogenesis of the liver fibrosis development and progression in chronic hepatitis C
by: M. A. Shishkin
Published: (2015-04-01)

Pathomorphology of liver fibrosis in trepanobioptates of patients with steatohepatitis: main types, sources of development, features of progression
by: V. A. Tumanskiy, et al.
Published: (2017-12-01)

Insights into the impact of hepatitis B virus on hepatic stellate cell activation
by: Hongjuan You, et al.
Published: (2023-04-01)

Hepatic expression of cannabinoid receptors CB1 and CB2 correlate with fibrogenesis in patients with chronic hepatitis B
by: Erhei Dai, et al.
Published: (2017-06-01)

The Origin and Fate of Liver MyofibroblastsSummary
by: Hyun Young Kim, et al.
Published: (2024-01-01)

Salvianolic acid B blocks hepatic stellate cell activation via FGF19/FGFR4 signaling
by: Shuxia Tian, et al.
Published: (2021-01-01)

Progress of researches on inducing hepatic stellate cell ferroptosis for treatment of liver fibrosis
by: SUN Lijie, HAO Dandan
Published: (2024-01-01)

Histopathological features of chronic hepatitis B reactivation
by: Remzi Bestas, et al.
Published: (2020-09-01)

RANKL inhibits activation of hepatic stellate cells during hepatic fibrosis in mice
by: ZHOU Lijia, et al.
Published: (2023-01-01)

Current Therapy of Chronic Viral Hepatitis B, C and D
by: Jörg F. Schlaak
Published: (2023-06-01)

Hepatic stellate cells activation and liver fibrosis after chronic administration of ethanol
by: Kot-Bakiera Katarzyna, et al.
Published: (2016-06-01)

Relationship between hepatitis B DNA Viral load in the liver and it\'s histology in patient with chronic hepatitis B
by: Tahmineh Biazar, et al.
Published: (2015-10-01)

The role of hepatic stellate cells in fibrotic liver diseases
by: Hye Jin Cho, et al.
Published: (2020-03-01)

Ongoing involvers and promising therapeutic targets of hepatic fibrosis: The hepatic immune microenvironment
by: Nana Zhang, et al.
Published: (2023-02-01)

Epigenetic Regulation of Hepatic Stellate Cell Activation and Macrophage in Chronic Liver Inflammation
by: Chun-xia Shi, et al.
Published: (2021-07-01)

Can Viral Load Predict Liver Histology in Patients With Chronic Hepatitis B?
by: Ashraf Karbasi, et al.
Published: (2015-02-01)

RNA Sequencing and Bioinformatics Analysis Implicate the Regulatory Role of a Long Noncoding RNA-mRNA Network in Hepatic Stellate Cell Activation
by: Can-Jie Guo, et al.
Published: (2017-08-01)

Association of NK Cells with the Severity of Fibrosis in Patients with Chronic Hepatitis C
by: Anna Kleczka, et al.
Published: (2023-06-01)

Fibrotic Events in the Progression of Cholestatic Liver Disease
by: Hanghang Wu, et al.
Published: (2021-05-01)

Reelin expression in human liver of patients with chronic hepatitis C infection
by: Simone Carotti, et al.
Published: (2017-03-01)

Intercellular interactions and their role in fibrogenesis in chronic hepatitis C
by: I. A. Karabak, et al.
Published: (2022-05-01)

Phomopsterone B Alleviates Liver Fibrosis through mTOR-Mediated Autophagy and Apoptosis Pathway
by: Mei-Lin Peng, et al.
Published: (2024-01-01)

Current Condition of Chronic Hepatitis B Virus Infection in Cuban Adults
by: Castellanos Fernández Marlen Ivón, MD, PhD, MP, et al.
Published: (2017-01-01)

A study on outcome of hepatic fibrosis in chronic hepatitis B patients on anti-viral therapy
by: Avick Nag, et al.
Published: (2024-02-01)

The Effects of Irisin on the Interaction between Hepatic Stellate Cell and Macrophage in Liver Fibrosis
by: Dinh Vinh Do, et al.
Published: (2022-08-01)

Role of Fibroblast Growth Factors in the Crosstalk of Hepatic Stellate Cells and Uveal Melanoma Cells in the Liver Metastatic Niche
by: Tatjana Seitz, et al.
Published: (2022-09-01)

HCV virological response during treatment of chronic hepatitis C is associated with liver histological Improvement in patients with HCV/HIV co-infection
by: Gleusa Castro, et al.

Demethyleneberberine Protects against Hepatic Fibrosis in Mice by Modulating NF-κB Signaling
by: Yongchen Wang, et al.
Published: (2016-06-01)

Downregulation of KIAA1199 alleviated the activation, proliferation, and migration of hepatic stellate cells by the inhibition of epithelial–mesenchymal transition
by: Liu Jingmei, et al.
Published: (2023-04-01)

Autophagy and Exosomes: Cross-Regulated Pathways Playing Major Roles in Hepatic Stellate Cells Activation and Liver Fibrosis
by: Eleftheria M. Mastoridou, et al.
Published: (2022-02-01)

Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated mice
by: Takemasa Senoo, et al.
Published: (2018-02-01)

Elastin in the Liver
by: Jiri Kanta
Published: (2016-10-01)

Receiver Operating Characteristic Analysis of Liver Function Tests in Patients with Chronic Viral Hepatitis B in Baghdad, Iraq
by: Rana T. Mohsen
Published: (2023-12-01)

Clinicopathologic features of dual chronic hepatitis B and C infection: A comparison with single hepatitis B, C and delta infections
by: Hakan Senturk, et al.
Published: (2008-01-01)

Research progress of therapeutic vaccines for treating chronic hepatitis B
by: Jianqiang Li, et al.
Published: (2017-05-01)

Current role of transient elastography in the management of chronic hepatitis B patients
by: Jung Hwan Yu, et al.
Published: (2017-04-01)

Eritoran Attenuates Hepatic Inflammation and Fibrosis in Mice with Chronic Liver Injury
by: Yun-Cheng Hsieh, et al.
Published: (2021-06-01)

The role of different viral biomarkers on the management of chronic hepatitis B
by: Lung-Yi Mak, et al.
Published: (2023-04-01)

PATHOHISTOLOGICAL AND IMMUNOHISTOCHEMICAL FEATURES OF THE ENDOMETRIUM IN CHRONIC ENDOMETRITIS IN WOMEN WITH INFERTILITY (LITERATURE REVIEW)
by: Danilyuk S. V., et al.
Published: (2020-12-01)